Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Astellas to Abolish Pay Structure for Sales Reps, Switching to Company-Wide System Next April
December 20, 2021
-
BUSINESS Pfizer Agrees to Supply Oral COVID-19 Drugs for 2 Million People in Japan
December 20, 2021
-
BUSINESS Biogen to Challenge European Rejection of Aducanumab
December 20, 2021
-
BUSINESS Moderna to Develop All Global Pipeline Assets in Japan without Delay: Local Chief
December 17, 2021
-
BUSINESS Shionogi Pharma Eyes 10 Billion Yen Sales in CDMO Business in FY2022
December 17, 2021
-
REGULATORY Japan Approves Moderna Vaccine for COVID-19 Booster
December 16, 2021
-
REGULATORY Japan Panel OKs Moderna COVID-19 Vaccine for Booster Use
December 16, 2021
-
REGULATORY Aducanumab Up for Japan Advisory Panel Review on December 22
December 15, 2021
-
REGULATORY MHLW Calls for Lifting of Shipment Restrictions for 130 Generic API/Specifications after Survey Finds YOY Rise in Supplies
December 14, 2021
-
BUSINESS Chugai Files Actemra for COVID-19 Pneumonia in Japan
December 14, 2021
-
REGULATORY METI to Dole Out Support for “Dual-Use” Production Bases to Boost Pandemic Preparedness
December 13, 2021
-
REGULATORY Fiscal Discipline for Drug Spending Could Be Discussed towards FY2023: MOF Budget Examiner
December 10, 2021
-
REGULATORY E Keppra Generics from 12 Firms to Join NHI Price List, Patanol and Velcade AGs Too
December 9, 2021
-
ACADEMIA With First Ophthalmologic Biosimilar Set to Debut, Specialist Says Close Attention Required for Unexpected Side Effects
December 9, 2021
-
REGULATORY Moderna COVID-19 Booster Up for Panel Review on Dec. 15
December 9, 2021
-
REGULATORY MHLW Warns against Hoarding on 17 APIs as Hitachi Fire Stirs Supply Worries
December 8, 2021
-
BUSINESS EU Panel Backs Tocilizumab for Severe COVID-19: Chugai
December 8, 2021
-
BUSINESS Horizon Plants Flag in Japan Soil to Gear Up for Thyroid Eye Disease Trial
December 7, 2021
-
REGULATORY BMS’ Second CAR-T Therapy Ide-Cel in Line for Approval in January
December 7, 2021
-
BUSINESS Towa Bags Approval of Edirol AG through Partial Change of Its Version
December 7, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…